CLS (LON:CLI)‘s stock had its “buy” rating reaffirmed by analysts at Liberum Capital in a research report issued on Tuesday. They currently have a GBX 300 ($4.14) price objective on the stock. Liberum Capital’s price objective points to a potential upside of 26.58% from the company’s previous close.
Separately, Peel Hunt upped their target price on CLS from GBX 250 ($3.45) to GBX 265 ($3.66) and gave the stock a “buy” rating in a research report on Wednesday, March 7th.
CLS (LON:CLI) opened at GBX 237 ($3.27) on Tuesday. CLS has a 12-month low of GBX 170.22 ($2.35) and a 12-month high of GBX 256.42 ($3.54). The firm has a market capitalization of $959.42 and a P/E ratio of 607.69.
In other news, insider Sten A. Mortstedt bought 107,000 shares of the stock in a transaction dated Thursday, March 8th. The shares were bought at an average cost of GBX 244 ($3.37) per share, with a total value of £261,080 ($360,707.38).
ILLEGAL ACTIVITY NOTICE: This story was first published by Markets Daily and is owned by of Markets Daily. If you are reading this story on another website, it was stolen and reposted in violation of US and international copyright and trademark legislation. The legal version of this story can be read at https://www.themarketsdaily.com/2018/03/13/cls-cli-rating-reiterated-by-liberum-capital.html.
CLS Holdings plc is a United Kingdom-based investment property company. The Company is principally involved in the investment, management and development of commercial properties, and in other investments. The Company’s business activity is the investment in commercial real estate across four European regions, such as London, the rest of the United Kingdom, Germany and France with a focus on providing offices in key European cities.
Receive News & Ratings for CLS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CLS and related companies with MarketBeat.com's FREE daily email newsletter.